Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06937125

Evaluation of Valvular Heart Disease Using Cardiac CT

Evaluation of Valvular Heart Disease: Multicenter Registry of Noninvasive Imaging Modalities by Cardiac CT

Status
Recruiting
Phase
Study type
Observational
Enrollment
350 (estimated)
Sponsor
Toho University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The EVIDENTIA Registry is a multicenter study designed to evaluate valvular heart disease (VHD) using cardiac CT. It aims to assess cardiac valve anatomy, function, and myocardial characteristics through detailed CT analysis. 1. Assessing the accuracy of cardiac CT in evaluating cardiac structure, volume, function, and myocardium in VHD patients. 2. Comparing the severity, classification, and etiology (primary vs. functional) of VHD. 3. Monitoring serial changes in VHD severity via echocardiography. 4. Investigating the relationship between echocardiographic and CT-derived parameters. 5. Examining the correlation between imaging findings, VHD interventions, and patient prognosis.

Conditions

Timeline

Start date
2025-03-12
Primary completion
2027-03-01
Completion
2028-03-01
First posted
2025-04-22
Last updated
2025-05-14

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT06937125. Inclusion in this directory is not an endorsement.